← Back to Search

Other

[14C]-BMS-986196 for Healthy Volunteers

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 29
Awards & highlights

Study Summary

This trial tests how a drug is absorbed and how safe it is when taken orally, to see if it is fit for use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 29
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 29 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
TRA: Amount of radioactivity recovered in bile (BR)
TRA: Amount of radioactivity recovered in feces (FR)
TRA: Amount of radioactivity recovered in urine (UR)
+6 more
Secondary outcome measures
AUC (0-T)
Cmax
Number of Participants with AEs Leading to Discontinuation
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: [14C]-BMS-986196Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[14C]-BMS-986196
2023
Completed Phase 1
~10

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,638 Previous Clinical Trials
4,128,492 Total Patients Enrolled

Media Library

[14C]-BMS-986196 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05981963 — Phase 1
Healthy Volunteers Research Study Groups: [14C]-BMS-986196
Healthy Volunteers Clinical Trial 2023: [14C]-BMS-986196 Highlights & Side Effects. Trial Name: NCT05981963 — Phase 1
[14C]-BMS-986196 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05981963 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical trial extend its eligibility to individuals of advanced age?

"Patients over the age of 18 and less than 55 years old may participate in this trial."

Answered by AI

Is enrollment for this medical study still available?

"This clinical trial targets 8 healthy volunteers between the ages of 18-55. Appropriate participants must meet these criteria to be considered for this investigation."

Answered by AI

Is recruitment open for this research project?

"Confirmed - the clinicaltrials.gov page for this medical trial indicates that it is not accepting patients at present, despite being initially posted on August 17th 2023 and edited as recently as August 1st 2023. Nevertheless, 3 other studies are seeking enrolment from volunteers right now."

Answered by AI

Could you please elucidate the degree of safety for patients taking [14C]-BMS-986196?

"Due to the limited data regarding [14C]-BMS-986196's efficacy and safety, our team at Power gave it a score of 1."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
2023. "A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05981963.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top